Market Valuation
Global market valuation north of $4 billion for oral airways in our three target segments
Procedures
Over 250,000,000 procedures performed globally each year within this segment
Discount
10% discount offered to those investors who invest in the convertible bonds
Annual Interest
Three year convertible note with 10% yearly return compounding annually
Interested in
Download our investment flyer and learn how Arete is revolutionizing the oral airway industry!
To advance patient care through innovative, reliable, and accessible medical technologies that empower healthcare providers and improve outcomes worldwide.
To become a global leader in medical device innovation, setting new standards for safety, efficiency, and affordability while expanding access to life-changing healthcare solutions.
Innovation First: Proprietary technologies developed with rigorous R&D and clinical validation.
Patient-Centered Design: Devices engineered for usability, safety, and measurable impact on patient health.
Trust & Compliance: Commitment to regulatory excellence, ethical practices, and transparent investor relations.
Scalable Growth: Positioned in a rapidly expanding medical device market with strong potential for adoption and global reach.
Click the Button Below to Contact Investor Relations
Click Here
The global medical device industry is projected to exceed $600 billion in the coming years, driven by aging populations, chronic disease management, and demand for innovative technologies.
Arete is positioned to capture market share with solutions that address unmet clinical needs and streamline healthcare delivery.
Proprietary technologies developed through rigorous R&D and clinical validation.
Focus on devices that improve patient outcomes while reducing costs for providers and payers.
Strong intellectual property portfolio and ongoing patent development.
Patient-Centered Design: Devices engineered for usability, safety, and measurable impact.
Regulatory Excellence: Commitment to compliance and quality standards ensures faster approvals and market entry.
Strategic Partnerships: Collaborations with healthcare providers, research institutions, and distributors strengthen adoption.
Achieved key development milestones including prototype validation and early clinical feedback.
Secured initial funding and grants to support growth.
Pipeline includes products advancing toward FDA clearance and commercialization.
Business model designed for scalability across multiple markets and geographies.
Opportunities for recurring revenue through device sales, service contracts, and licensing.
Positioned for long-term growth with a clear path to profitability.
Dedicated to improving access to healthcare and reducing systemic costs.
Transparent governance and sustainability practices that align with investor values.
Social impact: advancing technologies that directly improve patient lives.
